Literature DB >> 27716748

Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy.

F Ricci1, M Parravano2, F Regine1, M Sciamanna2, M Tedeschi2, F Missiroli1, M Varano2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27716748      PMCID： PMC5233939          DOI： 10.1038/eye.2016.215

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  2 in total

1.  Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy.

Authors:  D Călugăru; M Călugăru
Journal:  Eye (Lond)       Date:  2016-10-07       Impact factor: 3.775

2.  Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy.

Authors:  F Ricci; M Parravano; F Regine; M Sciamanna; M Tedeschi; F Missiroli; M Varano
Journal:  Eye (Lond)       Date:  2016-05-27       Impact factor: 3.775
  2 in total
  1 in total

1.  WARE: Wet AMD Risk-Evaluation Tool as a Clinical Decision-Support System Integrating Genetic and Non-Genetic Factors.

Authors:  Carlo Fabrizio; Andrea Termine; Valerio Caputo; Domenica Megalizzi; Stefania Zampatti; Benedetto Falsini; Andrea Cusumano; Chiara Maria Eandi; Federico Ricci; Emiliano Giardina; Claudia Strafella; Raffaella Cascella
Journal:  J Pers Med       Date:  2022-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.